Evidence map›Paper›PMID 34351450›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2021

Postsurgical geometrical variations of tumor bed and brainstem during photon and proton therapy for pediatric tumors of the posterior fossa: dosimetric impact and predictive factors.

Stefania Volpe, Pierre-Yves Bondiau, Line Claude, Audrey Claren, Laetitia Padovani, Hamza AlGhamdi, Gwenaëlle Duhil De Benaze, Lucas Opitz, Guillaume Baudin, Catherine Dejean and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Stefania VolpeDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy. stefania.volpe@ieo.it.ORCID http://orcid.org/0000-0003-0498-2964
Pierre-Yves BondiauAntoine Lacassagne Centre, Department of Radiation Oncology, Fédération Claude-Lalanne, University of Côte d'Azur, Nice, France.
Line ClaudeDepartment of Radiation Oncology, Léon Bérard Centre, Lyon, France.
Audrey ClarenAntoine Lacassagne Centre, Department of Radiation Oncology, Fédération Claude-Lalanne, University of Côte d'Azur, Nice, France.
Laetitia PadovaniOncology Radiotherapy Department, CRCM Inserm, UMR1068, CNRS UMR7258, AMU UM105, Genome Instability and Carcinogenesis, Assistance Publique des Hôpitaux de Marseille, Aix-Marseille University, Marseille, France.
Hamza AlGhamdiAntoine Lacassagne Centre, Department of Radiation Oncology, Fédération Claude-Lalanne, University of Côte d'Azur, Nice, France.
Gwenaëlle Duhil De BenazePedatric Oncology, Archet Hospital, Nice, France.
Lucas OpitzAntoine-Lacassagne Centre, Department of Anesthesiology, University of Côte d'Azur, Nice, France.
Guillaume BaudinAntoine-Lacassagne Centre, Department of Radiology, University of Côte d'Azur, Nice, France.
Catherine DejeanAntoine Lacassagne Centre, Department of Radiation Oncology, Fédération Claude-Lalanne, University of Côte d'Azur, Nice, France.
Daniel ManevalAntoine Lacassagne Centre, Department of Radiation Oncology, Fédération Claude-Lalanne, University of Côte d'Azur, Nice, France.
Barbara Alicja Jereczek-FossaDivision of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Jérôme DoyenAntoine Lacassagne Centre, Department of Radiation Oncology, Fédération Claude-Lalanne, University of Côte d'Azur, Nice, France. jerome.doyen@nice.unicancer.fr.
Centre Antoine Lacassagne · FRUniversity of Milan · ITCentre Léon Bérard · FRCentre National de la Recherche Scientifique · FRHôpital l'Archet · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBrainstem radionecrosis is an important issue during the irradiation of tumors of the posterior fossa. The aim of the present study is to analyze postsurgical geometrical variations of tumor bed (TB) and brainstem (BS) and their impact on dosimetry.

methodsRetrospective collection of data from pediatric patients treated at a single institution. Availability of presurgical magnetic resonance imaging (MRI) was verified; availability of at least two postsurgical MRIs was considered a further inclusion criterion. The following metrics were analyzed: total volume, Dice similarity coefficient (DSC), and Haudsdorff distances (HD).

resultsFourteen patients were available for the quantification of major postsurgical geometrical variations of TB. DSC, HD max, and HD average values were 0.47 (range: 0.08;0.76), 11.3 mm (7.7;24.5), and 2.6 mm (0.7;6.7) between the first and the second postoperative MRI, respectively. Postsurgical geometrical variations of the BS were also observed. Coverage to the TB was reduced in one patient (D95: -2.9 Gy), while D2 to the BS was increased for the majority of patients. Overall, predictive factors for significant geometrical changes were presurgical gross tumor volume (GTV) > 33 mL, hydrocephaly at diagnosis, Luschka foramen involvement, and younger age (≤ 8 years).

conclusionMajor volume changes were observed in this cohort, with some dosimetric impact. The use of a recent co-registration MRI is advised. The 2-3 mm HD average observed should be considered in the planning target volume/planning organ at risk volume (PTV/PRV) margin and/or robust optimization planning. Results from wider efforts are needed to verify our findings.

Indexed as

Infratentorial NeoplasmsNeoplasmsProton TherapyBrain StemChildHumansRadiotherapy DosageRadiotherapy Planning, Computer-AssistedRetrospective StudiesCentral nervous system tumorsPediatric radiation oncologyProtontherapySurgical bedTreatment planning optimization

Identifiers

PMID34351450
OpenAlexW3191442300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.